Probing the active site of beta-lactamase R-TEM1 by informational suppression

Biochimie
F LenfantJ M Masson

Abstract

Using a new extended set of 13 amber suppressors in E coli, systematic amino-acid replacements were performed at positions 104(E) and 238(G) of TEM-1 beta-lactamase from PUC19. The enzyme is tolerant to most substitutions tested at position 104. Missense revertants E104K, E104S or E104Y exhibited only minor changes in enzyme activity with respect to wild-type TEM-1. Several substitutions at position 238 resulted in a new cefotaxime hydrolysing capacity, but to an extent that did not confer cefotaxime resistance for the bacteria producing the mutated enzymes. Only when the mutations at codons 104 and 238 were combined on the same gene, did a true cefotaxime resistant phenotype appear, mimicking the situation encountered with 3rd generation cephalosporins resistant clinical isolates.

References

Dec 1, 1977·Proceedings of the National Academy of Sciences of the United States of America·F SangerA R Coulson
Aug 1, 1989·Antimicrobial Agents and Chemotherapy·A PhilipponG Jacoby
Sep 1, 1989·Infection·A PhilipponA Ben Hassen
Mar 1, 1986·Proceedings of the National Academy of Sciences of the United States of America·S C Schultz, J H Richards
Sep 1, 1986·Proceedings of the National Academy of Sciences of the United States of America·J NormanlyJ H Miller
Apr 1, 1972·Antimicrobial Agents and Chemotherapy·C H O'CallaghanA H Shingler
Jan 1, 1970·Annual Review of Genetics·L Gorini
May 16, 1980·Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences·R P Ambler
Dec 1, 1982·Proceedings of the National Academy of Sciences of the United States of America·I S SigalR Arentzen
Feb 1, 1981·Journal of Bacteriology·D BradleyL Soll

❮ Previous
Next ❯

Citations

Sep 1, 1992·International Journal of Antimicrobial Agents·A C Fluit, M R Visser
Aug 1, 1991·Bio/technology·G A BowdenG Georgiou
Sep 20, 2006·Antimicrobial Agents and Chemotherapy·Christopher R BethelRobert A Bonomo
Jan 30, 2009·Protein Science : a Publication of the Protein Society·Pierre-Yves De WalsJoelle N Pelletier
Oct 3, 1998·The Journal of Biological Chemistry·C Cantu, T Palzkill

❮ Previous
Next ❯

Related Concepts

Related Feeds

Allergy & Infectious Diseases (ASM)

Allergies result from the hyperreactivity of the immune system to some environmental substance and can be life-threatening. Infectious diseases are caused by organisms including bacteria, viruses, fungi and parasites. They can be transmitted different ways, such as person-to-person. Here is the latest research on allergy and infectious diseases.

Antimicrobial Resistance (ASM)

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.

Antimicrobial Resistance

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.

Allergy & Infectious Diseases

Allergies result from the hyperreactivity of the immune system to some environmental substance and can be life-threatening. Infectious diseases are caused by organisms including bacteria, viruses, fungi and parasites. They can be transmitted different ways, such as person-to-person. Here is the latest research on allergy and infectious diseases.